# Koninklijke Philips NV (PHG)

- Sector: Healthcare · Industry: Medical Devices
- SEC CIK: 0000313216 ([filings on EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000313216))
- Full page: https://inspectstocks.com/stocks/phg
- Data as of: price 2026-09-25; newest filing used 2026-07-28; latest fiscal period ended 2026-06-30

## Grade

**D** on the balance-sheet rubric used for lenders, 2 of 5 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Profitable | passed |  |  |
| Earnings growing overall | passed |  |  |
| Earnings growing recently | failed |  |  |
| Earns well on its assets | failed |  |  |
| Book value per share growing | failed |  |  |

Business quality (the + / − mark): 2 of 5 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Profitable | passed |  |  |
| Healthy profit margin | failed |  |  |
| Strong operating margin | failed |  |  |
| Good return on equity | failed |  |  |
| Debt under control | passed |  |  |

How the grade works: the letter counts failed checks (none → A, one → B, two → C, three → D, four or more → F). It is built from SEC filings only — the share price never enters it — and describes the business, not whether the stock is worth buying.

## Key figures

In US dollars, converted from EUR at today's spot rate (every period alike).

| Measure | Value |
| --- | --- |
| Revenue, trailing twelve months | $20.1B |
| Net income, trailing twelve months | $1.3M |
| Net margin | 0.0% |
| Operating margin | 9.7% |
| Return on equity | 0.0% |
| Debt to equity | 0.83 |
| Diluted EPS, trailing twelve months | $1.06 |
| Share price | $24.96 |
| Market value | $24B |
| Price / earnings | 23.6x |
| Price / sales | 1.2x |

## More on this company

- [Overview](https://inspectstocks.com/stocks/phg)
- [Financial statements](https://inspectstocks.com/stocks/phg/financials)
- [Competitors](https://inspectstocks.com/stocks/phg/peers)
- [Earnings](https://inspectstocks.com/stocks/phg/earnings)

---

Source: InspectStocks, built from the company’s own SEC filings. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.